Resilience

Resilience

Cyber insurance paired with risk-quantifying SaaS

Overview

Resilience provides cyber insurance to mid-market and large enterprises and licenses the Resilience Solution, a SaaS platform that translates a company’s security posture into a financially oriented action plan used for underwriting and risk management. The platform quantifies technology controls, estimates ROI of security investments, and informs insurance pricing. It runs a risk operations center with continuous threat intelligence and in-house claims handling, emphasizing third-party risk. Goal: move beyond risk transfer by actively improving client security and reducing losses across sectors such as manufacturing, agriculture, and healthcare.

About Resilience

Simplify's Rating
Why Resilience is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Data & Analytics

Enterprise Software

Cybersecurity

Financial Services

Company Size

1,001-5,000

Company Stage

Grant

Total Funding

$2.5B

Headquarters

San Diego, California

Founded

2020

Simplify Jobs

Simplify's Take

What believers are saying

  • Large-enterprise buyers need financial justification for security spend.
  • Third-party risk monitoring addresses a major claims and loss source.
  • Industry-leading loss ratio supports underwriting credibility and capacity expansion.

What critics are saying

  • Integration complexity can slow sales cycles and implementation.
  • Heavy dependence on insurance capacity exposes revenue to market tightening.
  • Competitors can undercut pricing on software-only or insurance-only offerings.

What makes Resilience unique

  • Integrates cyber insurance with risk-quantification software and security services.
  • Uses claims data to translate controls into dollar-based action plans.
  • Provides in-house claims handling and continuous risk operations monitoring.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$2.5B

Above

Industry Average

Funded Over

6 Rounds

Grant funding comparison data is currently unavailable. We're working to provide this information soon!
Grant Funding Comparison
Coming Soon

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Company Match

Unlimited Paid Time Off

Paid Holidays

Family Planning Benefits

Fertility Treatment Support

Tuition Reimbursement

Performance Bonus

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

-1%

2 year growth

0%
InvestorWire
May 26th, 2026
InvestorNewsBreaks - Redwood AI Corp. (CSE: AIRX) (OTCQB: RDWCF) (Frankfurt: Y0N) (WKN: A422EZ) Collaborates with Resilience Biosciences on AI-Driven Drug Discovery.

InvestorNewsBreaks - Redwood AI Corp. (CSE: AIRX) (OTCQB: RDWCF) (Frankfurt: Y0N) (WKN: A422EZ) Collaborates with Resilience Biosciences on AI-Driven Drug Discovery. Redwood AI (CSE: AIRX) (OTCQB: RDWCF) (Frankfurt: Y0N) (WKN: A422EZ) announced a collaboration with Resilience Biosciences Inc. to support the development and evaluation of AI-assisted computational chemistry workflows for small-molecule drug development, with the goal of improving efficiency in identifying, analyzing and advancing potential drug candidates. The collaboration will apply Redwood's computational chemistry, cheminformatics and synthetic route design capabilities to support Resilience's non-opioid therapeutic development programs, including workflows for derivative generation, patentability and freedom-to-operate analysis, and retrosynthetic planning aimed at accelerating early-stage drug discovery and development. About Redwood AI Corp. Redwood AI uses advanced artificial intelligence to accelerate chemistry R&D, with the aim of assisting in drug discovery and development, and furthering defense and safety solutions. The Company combines expertise in chemistry, AI, and manufacturing to streamline drug synthesis and scale-up. Redwood AI's platform is designed to enable faster, more efficient development of new therapies and chemistry-driven applications. About InvestorWire InvestorWire ("IW") is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today's market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge. Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer InvestorWire is powered by IBN

Resilience
Oct 29th, 2025
Resilience Announces Long-Term Financing of up to $825 Million to Accelerate CDMO Strategy

PRESS RELEASE: Resilience Announces Long-Term Financing of up to $825 Million to Accelerate CDMO Strategy

Stock Titan
Jul 10th, 2025
Vor Bio Appoints Veteran Biotech Executive Sandy Mahatme as Chief Financial Officer and Chief Business Officer

Mahatme brings over 30 years of executive leadership experience in the biopharmaceutical industry, most recently serving as President, COO, and CFO of National Resilience, where he raised over $2.5 billion in capital.

CISC Project
May 12th, 2025
CISC project at the 66th ESReDA seminar: Collaborative intelligence and Human in the loop for the future of safety critical systems - Key lessons learned and future directions

CISC researchers to present at the 66th edition of the ESReDA Seminar on transformative Safety and Resilience in a digital, Sustainable World.

Steamboat Pilot & Today
May 6th, 2025
Resilience, self-love, fun key themes for Wellness Conference May 15

Resilience, self-love, co-regulation and the importance of remembering fun are some of the key educational themes for this year's Yampa Valley Wellness Conference organized by the nonprofit Health Partnership serving Northwest Colorado.

Recently Posted Jobs

Sign up to get curated job recommendations

Resilience is Hiring for 23 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →